# The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

> **NCT00442221** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 500 (—)

## Conditions studied

- Migraine Headaches

## Interventions

- **DRUG:** Sumatriptan and Naproxen sodium

## Key facts

- **NCT ID:** NCT00442221
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 500 (—)
- **Last updated:** 2007-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442221, "The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00442221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*